GAAP net loss for the third quarter of 2025 was $38.0 million, compared to $60.7 million for the third quarter of 2024. Non-GAAP net loss for the third quarter of 2025 was $36.8 million, compared to ...

A new method vastly improves on the existing approach for single-cell genetic sequencing, enabling scientists to read the ...

The study showcases an innovative and effective approach for large-scale genomic research of individual cells and viral ...

Overall, 5.05 percent of individuals carry pathogenic/likely pathogenic variants (P/LPVs) in key cancer susceptibility genes, ...

The two main approaches for discovering disease genes reveal distinct aspects of biology, a new study shows. While both ...

A newborn baby has received treatment for retinoblastoma after the condition was detected at birth through umbilical cord ...

With the introduction of ONT-based plasmid sequencing, Novogene further strengthens its position as a trusted hub for advanced sequencing solutions, expanding its capabilities in both long- and ...

A new genomic method has enabled multiple people with rare conditions to receive diagnoses that were previously unattainable ...